数量	カタログ番号	注文内容	Qty/Pk	価格
			96-Well Plate

数量	カタログ番号	注文内容	Qty/Pk	価格
	48-602MAG	Buffer Detection Kit for Magnetic Beads	1 Kit

234192 Sigma-AldrichAnti-Collagen Type VII Rabbit pAb

This Anti-Collagen Type VII Rabbit pAb is validated for use in Frozen Sections, Immunoblotting, Immunofluorescence, Immunoprecipitation for the detection of Collagen Type VII.

Anti-Collagen Type VII Rabbit pAb: のSDS（安全データシート）、CoA（試験成績書）およびCoQ（品質証明書）、カタログなど製品関連の技術資料を入手いただけます。

(M)SDS
試験成績書（CoA）
参考資料
Data Sheet

お勧めの製品

概要

Replacement Information

主要スペック表

Species Reactivity	Host	Antibody Type
H, Marmoset	Rb	Polyclonal Antibody

価格＆在庫状況

カタログ番号	在庫状況	包装	Qty/Pk	価格	数量
234192-500ULCN	在庫状況検索中… — 現在国内在庫なし現在国内在庫有り販売中止在庫僅少現在国内在庫あり在庫を照会するにはログインしてください現在国内在庫有り現在国内在庫なし現在国内在庫有り Remaining : Will advise Remaining : Will advise 注文対象外お問合せください Contact Customer Service お問合せくださいお問合せください	樹脂ｱﾝﾌﾟﾙ	500 ul	価格を検索中… 価格が見つかりません Minimum Quantity needs to be mulitiple of Maximum Quantity is 弊社照会詳細を表示　値引 () — 弊社照会納入価格を閲覧するにはログインしてください	在庫状況を照会 —	お気に入り/ショッピングリストに追加お気に入り/ショッピングリストに追加お気に入りに追加されました

Description
Overview	Recognizes type VII collagen. Does not cross-react with fibronectin or type I, type II, type III, type IV, or type VI collagen.
Catalogue Number	234192
Brand Family	Calbiochem®

References
References	Chen, M., et al. 1997. Invest. Dermatol. 108, 68. Hashimoto, T., et al. 1996. Br. J. Dermatol. 134, 336. Yasaka, N., et al. 1994. J. Dermatol. Sci. 7, 136.

Product Information
Form	Liquid
Preservative	≤0.1% sodium azide
Quality Level	MQ100

Applications
Key Applications	Frozen Sections Immunoblotting (Western Blotting) Immunofluorescence Immunoprecipitation
Application Notes	Frozen Sections (1:20-1:60, see comments) Immunoblotting (1:500-1:2000) Immunofluorescence (1:200) Immunoprecipitation (1:40-1:100)
Application Comments	Does not cross-react with fibronectin or other collagen types I, II, III, IV, or VI. For frozen sections, enzymatic or heat (41°C) pretreatment is recommended to unwind the triple helical structure. Antibody should be titrated for optimal results in individual systems. This protocol is provided only as a general guide. Researchers should standardize this assay for their own specific needs and should consult published literature. Immunohistochemistry Protocol Introduction Staining of cryosections using anti-collagen antibodies requires either heat and/or enzymatic treatment in order to unwind the triple helical structure of collagen. An initial heat treatment aids in unwinding the collagen, while maintaining the antigen structure. Subsequent enzymatic treatment with hyaluronidase facilitates the removal of macromolecules that further hinder recognition by the antibody. In some cases it is also necessary to perform a second enzymatic digestion using chondroitinase ABC. Protocol Reagents and Equipment: • Cryostat sections of desired tissue: cut into 5 mm sections and place on clean glass slides treated with poly-L-lysine • PBS (phosphate buffered saline): dissolve 8 g NaCl, 200 mg KCl, 1.44 g Na₂HPO₄, and 240 mg KH₂PO₄ in 800 ml dH₂O; adjust the pH to 7.4 with HCl; add dH₂O to 1 L • PBS/BSA (phosphate buffered saline/bovine serum albumin): 0.5% BSA prepared in PBS • Testicular hyaluronidase: 2 mg/ml in cold PBS • Chondroitinase ABC: 2 mg/ml in PBS • Normal sheep serum • Primary antibody: Anti-Collagen, Type VII Rabbit pAb (Cat. No. 234192); diluted as recommended • Secondary antibody: goat anti-rabbit IgG, fluorescein conjugated • p-Phenylenediamine: 0.1% in glycerin:PBS (9:1) • Staining chamber • Wet chamber for incubations: chamber in which a small amount of PBS or dH₂O is added to maintain a humid environment; slides should not be submerged Protocol: • Prepare 5 µm cryostat tissue sections from the tissue of choice and place on clean glass slides that have been treated with poly-L-lysine. • Incubate the tissue sections in a staining chamber with 0.5% BSA/PBS for 5-10 min at 41°-43°C. This serves to block the sections and unwind the helical structure. • Carefully rinse by briefly submerging in PBS. • Wash 2 x 10 min in PBS. Carefully remove excess fluid and air-dry the slides. • Treat the sections with 10 µl of hyaluronidase stock (2 mg/ml) by applying the enzyme directly to the sections on the slide. If 10 µl does not completely cover the section, increase the volume of enzyme until the section is completely covered. Incubate in a wet chamber at room temperature for 30 min. Stop the reaction by treatment of the sections with 25-50 µl of normal sheep serum. • Carefully rinse by briefly submerging in PBS. • Wash 2 x 10 min in PBS. Carefully remove excess fluid and air-dry the slides. • If desired, a second enzymatic treatment can be carried out by treating the sections with 10 µl of chondroitinase ABC (2 mg/ml); apply directly to the sections as above. If 10 µl does not completely cover the section, increase the volume of enzyme until the section is completely covered. Incubate in a wet chamber at room temperature for 30 min. Stop the reaction by treatment of the sections with 25-50 µl of normal sheep serum. • Carefully rinse by briefly submerging in PBS. • Wash 2 x 10 min in PBS. Carefully remove excess fluid and air-dry the slides. • Apply 5-10 µl of primary antibody (diluted to the desired concentration) to the section and incubate in a wet chamber at 37°C for 45 min. • Carefully rinse by briefly submerging in PBS. • Wash 2 x 10 min in PBS. Carefully remove excess fluid and air-dry the slides. • Apply 5-10 µl of secondary antibody (diluted to the desired concentration) to the section and incubate in a wet chamber at 37°C for 1 h. Protect from light during the incubation. • Carefully rinse by briefly submerging in PBS. • Wash 2 x 10 min in PBS in a staining chamber. Carefully remove excess fluid, but do not allow the slides to completely dry, as the secondary antibody may form crystals. • Place 1 drop of 0.1% p-phenylenediamine on the section and mount under a coverslip. The slides can be stored at 4°C up to 2 days. • Fixation: The best results have been obtained on cryosections without fixation. The risk of collagen loss is relatively low, as its solubility in neutral buffer is negligible. However, other antigens may diffuse into the incubation medium and settle along adjacent tissue structures or form diffusion artifacts. If fixation is necessary, dehydration with ethanol or acetone at -20°C for 5-10 min is recommended. Fixation should take place following enzymatic treatment (step 5). Aldehyde (formaldehyde or glutaraldehyde) fixation is NOT recommended. If aldehyde fixation cannot be avoided, do not exceed 2% of the fixative (less than 1% is recommended). Notes: • It may not be necessary to treat the sections with both heat and hyaluronidase and/or chondroitinase ABC. It is recommended that heat treatment be used initially and, if further epitope exposure is necessary, then treat with hyaluronidase. Chondroitinase ABC treatment is usually not necessary. • If hyaluronidase and chondroitinase ABC are both desired, it is recommended that the digestions be carried out separately.

Biological Information
Immunogen	purified, human placenta collagen type VII
Immunogen	Human
Host	Rabbit
Isotype	IgG
Species Reactivity	Human Marmoset
Antibody Type	Polyclonal Antibody

Physicochemical Information

Dimensions

Materials Information

Toxicological Information

Safety Information according to GHS

Safety Information

Product Usage Statements

Storage and Shipping Information
Ship Code	Dry Ice Only
Toxicity	Standard Handling
Storage	≤ -70°C
Avoid freeze/thaw	Avoid freeze/thaw
Do not freeze	Ok to freeze
Special Instructions	Following initial thaw, aliquot and freeze (-70°C).

Packaging Information

Transport Information

Supplemental Information

Specifications

Global Trade Item Number
カタログ番号	GTIN
234192-500ULCN	04055977200102

Documentation

Anti-Collagen Type VII Rabbit pAb (M)SDS

タイトル
英語版製品安全データシート（(M)SDS）

Anti-Collagen Type VII Rabbit pAb 試験成績書（CoA）

タイトル	ロット番号
234192	ロット番号を入力

参考資料

参考資料の概要
Chen, M., et al. 1997. Invest. Dermatol. 108, 68. Hashimoto, T., et al. 1996. Br. J. Dermatol. 134, 336. Yasaka, N., et al. 1994. J. Dermatol. Sci. 7, 136.

データシート

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision	26-July-2007 RFH
Application	Frozen Sections (1:20-1:60, see comments) Immunoblotting (1:500-1:2000) Immunofluorescence (1:200) Immunoprecipitation (1:40-1:100)
Description	Rabbit polyclonal antibody supplied as undiluted serum. Recognizes type VII collagen.
Background	Collagens are major fibrous structural elements of cartilage, tendon, bone, skin, lung, and blood vessels. Type VII collagen exists as a dimer of two triple helical coils, each of which is composed of three a1 (VII) subunits. Type VII collagen forms a major portion of anchoring fibrils that provide for the structural stability of subbasal lamina. Type VII collagen is associated with type IV collagen in anchoring plaques.
Host	Rabbit
Immunogen species	Human
Immunogen	purified, human placenta collagen type VII
Isotype	IgG
Species	human, marmoset
Form	Liquid
Preservative	≤0.1% sodium azide
Comments	Does not cross-react with fibronectin or other collagen types I, II, III, IV, or VI. For frozen sections, enzymatic or heat (41°C) pretreatment is recommended to unwind the triple helical structure. Antibody should be titrated for optimal results in individual systems. This protocol is provided only as a general guide. Researchers should standardize this assay for their own specific needs and should consult published literature. Immunohistochemistry Protocol Introduction Staining of cryosections using anti-collagen antibodies requires either heat and/or enzymatic treatment in order to unwind the triple helical structure of collagen. An initial heat treatment aids in unwinding the collagen, while maintaining the antigen structure. Subsequent enzymatic treatment with hyaluronidase facilitates the removal of macromolecules that further hinder recognition by the antibody. In some cases it is also necessary to perform a second enzymatic digestion using chondroitinase ABC. Protocol Reagents and Equipment: • Cryostat sections of desired tissue: cut into 5 mm sections and place on clean glass slides treated with poly-L-lysine • PBS (phosphate buffered saline): dissolve 8 g NaCl, 200 mg KCl, 1.44 g Na₂HPO₄, and 240 mg KH₂PO₄ in 800 ml dH₂O; adjust the pH to 7.4 with HCl; add dH₂O to 1 L • PBS/BSA (phosphate buffered saline/bovine serum albumin): 0.5% BSA prepared in PBS • Testicular hyaluronidase: 2 mg/ml in cold PBS • Chondroitinase ABC: 2 mg/ml in PBS • Normal sheep serum • Primary antibody: Anti-Collagen, Type VII Rabbit pAb (Cat. No. 234192); diluted as recommended • Secondary antibody: goat anti-rabbit IgG, fluorescein conjugated • p-Phenylenediamine: 0.1% in glycerin:PBS (9:1) • Staining chamber • Wet chamber for incubations: chamber in which a small amount of PBS or dH₂O is added to maintain a humid environment; slides should not be submerged Protocol: • Prepare 5 µm cryostat tissue sections from the tissue of choice and place on clean glass slides that have been treated with poly-L-lysine. • Incubate the tissue sections in a staining chamber with 0.5% BSA/PBS for 5-10 min at 41°-43°C. This serves to block the sections and unwind the helical structure. • Carefully rinse by briefly submerging in PBS. • Wash 2 x 10 min in PBS. Carefully remove excess fluid and air-dry the slides. • Treat the sections with 10 µl of hyaluronidase stock (2 mg/ml) by applying the enzyme directly to the sections on the slide. If 10 µl does not completely cover the section, increase the volume of enzyme until the section is completely covered. Incubate in a wet chamber at room temperature for 30 min. Stop the reaction by treatment of the sections with 25-50 µl of normal sheep serum. • Carefully rinse by briefly submerging in PBS. • Wash 2 x 10 min in PBS. Carefully remove excess fluid and air-dry the slides. • If desired, a second enzymatic treatment can be carried out by treating the sections with 10 µl of chondroitinase ABC (2 mg/ml); apply directly to the sections as above. If 10 µl does not completely cover the section, increase the volume of enzyme until the section is completely covered. Incubate in a wet chamber at room temperature for 30 min. Stop the reaction by treatment of the sections with 25-50 µl of normal sheep serum. • Carefully rinse by briefly submerging in PBS. • Wash 2 x 10 min in PBS. Carefully remove excess fluid and air-dry the slides. • Apply 5-10 µl of primary antibody (diluted to the desired concentration) to the section and incubate in a wet chamber at 37°C for 45 min. • Carefully rinse by briefly submerging in PBS. • Wash 2 x 10 min in PBS. Carefully remove excess fluid and air-dry the slides. • Apply 5-10 µl of secondary antibody (diluted to the desired concentration) to the section and incubate in a wet chamber at 37°C for 1 h. Protect from light during the incubation. • Carefully rinse by briefly submerging in PBS. • Wash 2 x 10 min in PBS in a staining chamber. Carefully remove excess fluid, but do not allow the slides to completely dry, as the secondary antibody may form crystals. • Place 1 drop of 0.1% p-phenylenediamine on the section and mount under a coverslip. The slides can be stored at 4°C up to 2 days. • Fixation: The best results have been obtained on cryosections without fixation. The risk of collagen loss is relatively low, as its solubility in neutral buffer is negligible. However, other antigens may diffuse into the incubation medium and settle along adjacent tissue structures or form diffusion artifacts. If fixation is necessary, dehydration with ethanol or acetone at -20°C for 5-10 min is recommended. Fixation should take place following enzymatic treatment (step 5). Aldehyde (formaldehyde or glutaraldehyde) fixation is NOT recommended. If aldehyde fixation cannot be avoided, do not exceed 2% of the fixative (less than 1% is recommended). Notes: • It may not be necessary to treat the sections with both heat and hyaluronidase and/or chondroitinase ABC. It is recommended that heat treatment be used initially and, if further epitope exposure is necessary, then treat with hyaluronidase. Chondroitinase ABC treatment is usually not necessary. • If hyaluronidase and chondroitinase ABC are both desired, it is recommended that the digestions be carried out separately.
Storage	Avoid freeze/thaw ≤ -70°C
Do Not Freeze	Ok to freeze
Special Instructions	Following initial thaw, aliquot and freeze (-70°C).
Toxicity	Standard Handling
References	Chen, M., et al. 1997. Invest. Dermatol. 108, 68. Hashimoto, T., et al. 1996. Br. J. Dermatol. 134, 336. Yasaka, N., et al. 1994. J. Dermatol. Sci. 7, 136.

カテゴリー

Life Science Research > Antibodies and Assays > Primary Antibodies

製品がカートに追加されました